Trial Profile
Induction Chemotherapy Followed by Chemoradiation With Cetuximab and Cisplatin for Inoperable Squamous Cell Carcinoma of the Head and Neck.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jan 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Docetaxel; Fluorouracil
- Indications Head and neck cancer
- Focus Therapeutic Use
- 23 Oct 2011 Actual end date changed from 1 Apr 2010 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 22 Nov 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 22 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.